http://www.businesswire.com/news/home/20260913549808/en/Ivonescimab-Monotherapy-Demonstrates-a-Statistically-Significant-Clinically-Meaningful-Benefit-Compared-to-Pembrolizumab-Monotherapy-in-PD-L1-Positive-Advanced-NSCLC-in-Akeso%E2%80%99s-HARMONi-2-Study-Conducted-in-China 2026-09-13T04:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260913293425/en/Glenfarne-Group-Promotes-Oliver-Wood-to-Global-Head-of-Projects 2026-09-13T04:00:00.000-07:00 weekly 0.5